In This Section      
Print This Page

Research Trials: Oncology

For more information, please contact Suburban Hospital Oncology Research:
Barbara Squiller: 301-896-2719
Melissa Hyman: 301-896-3221

TopicStudy NamePrincipal Investigator
BreastPlasma Tumor DNA and Pathologic Complete Response in Early-Stage, High-Risk Breast Cancer (TBCRC 040)
Learn more
Pamela Wright, M.D.
Head & NeckA pilot study to assess safety and feasibility of 5 fraction hypofractionated stereotactic radiosurgery (treating tumor and edema) along with standard temozolomide for newly diagnosed glioblastoma, including assessment of lymphocyte sparing effect. J1745
Learn more
Brandi Page, M.D.
BreastProspective survey of oncoplastic reduction for breast cancer. SIB1567
Call 301-896-2719 or 301-896-3221
Bonnie Sun, M.D.
ProstateStereotactic Body Radiation for Prostate Oligometastases(ORIOLE). J15180
Learn more
Stephen Greco, M.D.
Head & NeckSubventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme. J1426
Learn more
Brandi Page, M.D.
Head & NeckLow Dose Radiation Therapy for Glioblastoma Multiforme. J11120
Learn more
Brandi Page, M.D.
BreastOlaparib as Adjuvant Treatment in Patients with Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer (OlympiA). B55
Learn more
Carolyn B. Hendricks, M.D.
BreastThe IDEA Study (Individualized Decisions for Endocrine therapy Alone): A prospective, single-arm cohort study of patients receiving endocrine therapy alone (without radiotherapy) after breast conserving surgery for early-stage, post-menopausal breast cancer patients whose tumors have favorable biologic features. Learn moreSusan Stinson, M.D.
BreastA Randomized Phase III Trial Evaluating the Role of Axillary Lymph Node Dissection in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy. A011202 Learn morePamela Wright, M.D.
BreastA Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy . B-51 Learn moreSusan Stinson, M.D.
ProstateHypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate. J0859 Learn moreStephen Greco, M.D.
ProstateSALV-ENZA: Phase II Randomized Placebo-Controlled Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide in Men with High-Risk PSA-Recurrent Prostate Cancer after Radical Prostatectomy. J1454 Learn moreStephen Greco, M.D.
BladderA Phase II Protocol for Patients with Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging. R0926 Learn moreStephen Greco, M.D.
BreastPhase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. S1207 Learn MoreCarolyn B. Hendricks, M.D.
LiverLiver Y-90 Humanitarian Use of Intra-arterial Y-90 TheraSpheres for Hepatocellular Carcinoma or Hepatic Metastases from Solid Tumorschange PI. Call 301-896-2719 or 301-896-3221.Andrew Ackman, M.D.
BreastMolecular Genetic Studies in Cancer. Call 301-896-2719 or 301-896-3221Carolyn B.Hendricks, M.D.
BreastA Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS).E1Z11 Learn moreCarolyn B. Hendricks, M.D.
Indoor posed shot of the five-person Oncology Research Team Oncology Research Team